Pain Management: Cannabinoid Research Clinician Packet (Nationwide Edition)

A 14-page, doctor-facing review of the cannabinoid evidence for pain, from chronic pain overall to specific conditions, opioid co-use and safety signals.

Includes:

• Chronic pain overall (National Academies, BMJ and AHRQ-funded reviews)
• Neuropathic pain (Cochrane 2026), arthritis and back pain, fibromyalgia, migraine and cancer pain
• What studies show about opioid co-use (no tapering advice)
• Safety signals, including use disorder, driving and hyperemesis
• Professional positions (IASP, NIH) and medicines to flag for pharmacist review
• A patient-conversation checklist and a 50-state + DC program table (NCSL, October 2026)

Same clean format, 45 verified sources, same rules: no doses, no product recommendations.

Education only. These guides are a research-navigation aid. They are not medical, legal or prescribing advice. They do not diagnose, prescribe, recommend products, set doses or titration, or give drug-interaction verdicts. Findings are summarized for orientation only. Read the original sources before relying on any of them. Clinical decisions remain with the treating clinician. Confirm all laws and program rules on official state sites. For use with licensed, state-regulated medical cannabis programs and FDA-approved drugs only.

Sources include the National Academies of Sciences, Engineering, and Medicine (2017), Cochrane reviews, The BMJ, AHRQ-funded evidence reviews, the International Association for the Study of Pain (IASP), studies indexed in PubMed, NIH pages (NCCIH and others), FDA drug labels, the Federal Register, the National Conference of State Legislatures (NCSL), and official state program sites. This is an independent guide and is not endorsed by any cited source. Prepared by Annie Romelfanger, author of Medical Cannabis Handbook: A Friendly Guide to Safe, Simple Healing. Last reviewed: October 2026. Corrections: romelfanger@proton.me.